-

KBRA Assigns Rating to FS KKR Capital Corp.'s $300 million Senior Unsecured Notes due 2029

NEW YORK--(BUSINESS WIRE)--KBRA assigns a rating of BBB to FS KKR Capital Corp.'s (“FSK” or “the company”) $400 million 7.875% senior unsecured notes due 2029. The rating Outlook is Stable. The proceeds will be used for general corporate purposes, including the repayment of debt.

Key Credit Considerations

The ratings and Stable Outlook are supported by FS KKR Capital Corp.'s ties to KKR & Co., which has $510 billion of AUM, including $197 billion dedicated to private credit lending , along with FSK's SEC exemptive relief to co-invest among affiliated companies of KKR credit. As of September 30, 2023, FSK had a $14.7 billion well-diversified investment portfolio comprised mostly of senior secured first lien loans (60%) to 201 upper middle market companies within 24 industries. FSK focuses primarily on sponsor-backed companies that provide significant equity cushion with low LTVs. At 3Q23, the top four portfolio sectors were Software & Services (18%), Capital Goods (15%), Health Care Equipment & Services (12%), and Commercial & Professional Services (12%). The ratings also consider FSK's solid management team that has a long track record of working within the private debt markets with senior members each having decades of experience in leveraged finance. FSK is the second largest publicly traded BDC, which provides solid access to the capital markets evidenced by its $4.7 billion of senior unsecured debt outstanding. FSK's gross leverage (debt/equity) is appropriate at 1.15x with a prudent target net leverage range of 1.00x to 1.25x. KBRA favorably views the high proportion of unsecured debt to total debt of 59%, which allows for more asset unencumbrance for unsecured noteholders. Asset coverage was 187% with a 25% cushion, which KBRA considers appropriate, allowing FSK to absorb increased market volatility as well as a potential increase in non-accruals as the U.S. economy weakens with rising rates and inflation. Despite the potential for adverse credit headwinds in 2023 and into 2024, KBRA believes the company should weather a more difficult credit environment from management’s longterm experience, solid underwriting with a large portion of its corporate debt with at least one financial covenant, and a large proportion of investments in which FSK is lead, co-lead, or sole originator.

The rating strengths are counterbalanced by the potential risks related to the company’s elevated non-accruals as a percentage of total investments at 4.8% and 2.4% at cost and fair value, respectively, as of September 30, 2023, and its relatively high percentage of unsecured, ABL, joint venture, and equity investments at 32% of total investments. Additionally, like its peers, the company's assets are relatively illiquid and its retained earnings are constrained as a Regulated Investment Company (RIC).

FSK is an externally managed, closed-end, non-diversified investment management company that elected to be treated as a Business Development Company (BDC) under the 1940 Act as an RIC, which, among other things, must distribute to its shareholders at least 90% of the company’s investment company taxable income. The company is formed as a Maryland corporation. The company is managed by FS/KKR Advisor, LLC, a partnership of FS Investments and KKR Credit that was formed in 2018. The KKR Credit platform is a subsidiary of KKR & Co.

Rating Sensitivities

The ratings for FSK are unlikely to be upgraded in the intermediate term. A rating downgrade and/or Outlook change to Negative could be considered if a prolonged downturn in the U.S. economy has material impacts on performance and non-accruals that significantly affect capital, leverage, and liquidity metrics. An increased focus on riskier investments or a significant change in the current management structure coupled with a negative change in strategy, credit monitoring, and/or originations could also pressure ratings.

To access rating and relevant documents, click here.

Methodologies

Financial Institutions: Finance Company Global Rating Methodology
ESG Global Rating Methodology

Disclosures

A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here.

Information on the meaning of each rating category can be located here.

Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com.

About KBRA

Kroll Bond Rating Agency, LLC (KBRA) is a full-service credit rating agency registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a designated rating organization by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized by the National Association of Insurance Commissioners as a Credit Rating Provider.

Doc ID: 1002672

Contacts

Analytical Contacts
Kevin Kent, Director (Lead Analyst)
+1 301-960-7045
kevin.kent@kbra.com

Teri Seelig, Managing Director
+1 646-731-2386
teri.seelig@kbra.com

Joe Scott, Senior Managing Director
(Rating Committee Chair)
+1 646-731-2438
joe.scott@kbra.com

Business Development Contact
Constantine Schidlovsky, Senior Director
+1 646-731-1338
constantine.schidlovsky@kbra.com

Kroll Bond Rating Agency, LLC

Details
Headquarters: New York City, New York
CEO: Jim Nadler
Employees: 400+
Organization: PRI

Release Versions

Contacts

Analytical Contacts
Kevin Kent, Director (Lead Analyst)
+1 301-960-7045
kevin.kent@kbra.com

Teri Seelig, Managing Director
+1 646-731-2386
teri.seelig@kbra.com

Joe Scott, Senior Managing Director
(Rating Committee Chair)
+1 646-731-2438
joe.scott@kbra.com

Business Development Contact
Constantine Schidlovsky, Senior Director
+1 646-731-1338
constantine.schidlovsky@kbra.com

More News From Kroll Bond Rating Agency, LLC

KBRA Assigns Preliminary Ratings to Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 71 classes of mortgage pass-through certificates from Sequoia Mortgage Trust 2026-INV2 (SEMT 2026-INV2). The transaction consists of 1,118 investment property mortgages with an aggregate principal balance of $438.4 million as of the March 1, 2026 cut-off date. The collateral is characterized by a weighted average (WA) original credit score of 770 and moderate borrower equity, with a WA original LTV and WA original CLTV of 73.2%. KBR...

KBRA Assigns Preliminary Ratings to Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to six classes of notes issued by Research-Driven Pagaya Motor Asset Trust 2026-R1 and Research-Driven Pagaya Motor Trust 2026-R1 (collectively “RPM 2026-R1”), an auto loan ABS transaction. RPM 2026-R1 has initial credit enhancement levels of 35.69% for the Class A notes to 2.65% for the Class E-2 notes. Credit enhancement is comprised of overcollateralization, subordination of junior note classes (except for the Class E-2 notes), a ca...

KBRA Releases Research – What’s up, Doc – Medical Professional Mortgages, A New Niche in RMBS?

NEW YORK--(BUSINESS WIRE)--KBRA releases research assessing the characteristics of medical professional mortgage (MPM) loans, with a focus on their potential role as a niche collateral segment within the prime private label residential mortgage-backed securities (RMBS) market. MPMs, often called physician or doctor loans, are specialized prime mortgage programs designed for medical professionals whose early-career financial profiles often include high student debt, limited savings, and reliance...
Back to Newsroom